Imexon-based combination chemotherapy in A375 human melanoma and RPMI 8226 human myeloma cell lines
about
Imexon enhances gemcitabine cytotoxicity by inhibition of ribonucleotide reductase.Chitosan hydrogel for localized gene silencingAnti-tumor activity and mechanism of action for a cyanoaziridine-derivative, AMP423.Inhibition of protein synthesis by imexon reduces HIF-1alpha expression in normoxic and hypoxic pancreatic cancer cells.Potential usage of proteasome inhibitor bortezomib (Velcade, PS-341) in the treatment of metastatic melanoma: basic and clinical aspects
P2860
Imexon-based combination chemotherapy in A375 human melanoma and RPMI 8226 human myeloma cell lines
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Imexon-based combination chemo ...... 8226 human myeloma cell lines
@en
type
label
Imexon-based combination chemo ...... 8226 human myeloma cell lines
@en
prefLabel
Imexon-based combination chemo ...... 8226 human myeloma cell lines
@en
P2093
P2860
P1476
Imexon-based combination chemo ...... 8226 human myeloma cell lines
@en
P2093
Betty Samulitis
Julie Scott
Robert T Dorr
Terry H Landowski
P2860
P2888
P304
P356
10.1007/S00280-006-0329-Z
P577
2007-02-28T00:00:00Z